News Round-Up 2005
Published:
20/01/2005
Independent prescribing for pharmacists:
consultation due soon
The promised consultation on independent prescribing by pharmacists is
expected any day, according to a report in ‘The Pharmaceutical Journal’ (1/8
January, p8-9). The article discusses the different models of independent
prescribing that could be adopted, stressing the importance of a clear
definition of what independent prescribing for pharmacists is.
One possible model is a hybrid of independent and supplementary prescribing,
where the pharmacist diagnoses simple minor conditions but a doctor diagnoses
more complex conditions. After diagnosis, the pharmacist would be free to
choose the most appropriate treatment, without the restrictions of a CMP.
Another area for discussion is whether all independently prescribing
pharmacists should have access to the whole BNF or whether the formulary
should be restricted and, if so, how. The article also discusses how
independent prescribing might be used, in hospitals in community pharmacy,
out-of-hours services and residential and nursing care homes.
The question of separating dispensing and prescribing is also likely to arise,
and one suggestion is that it should be possible for prescribing and
dispensing to take place on the same premises but with a clear division of
responsibilities as a governance and safety check.
Other issues include: whether supplementary prescribing will continue;
antibiotic prescribing; funding and implementation; and workforce and training
issues.
Website:
Pharmaceutical Journal
Conference announcement: NPC meetings on
non-medical prescribing (20/01/05)
The National Prescribing Centre is organizing a series of six meetings in
England this year to “inform and enthuse” healthcare professionals interested
in the developments in independent and supplementary prescribing.
They are organized in association with ‘Prescriber’, are endorsed by the
Department of Health, and supported by “far-sighted pharmaceutical industry
partners”.
See here for further details.
Back to main news page
|